Literature DB >> 10715530

Immunoadjuvant activities of E. coli- and plasmid-expressed recombinant chicken IFN-alpha/beta, IFN-gamma and IL-1beta in 1-day- and 3-week-old chickens.

V E Schijns1, K C Weining, P Nuijten, E O Rijke, P Staeheli.   

Abstract

In the present study we assessed the capacity of recombinant E. coli- or plasmid-expressed chicken interferons (IFN) and chicken IL-1beta, to exert immunostimulatory activities for humoral immune responses, in day-old and adult chickens. We observed that both recombinant E. coli-expressed chicken IFN-alpha/beta and IFN-gamma facilitated the induction of a primary and also a secondary antibody response, using tetanus toxoid (TT) as a bacterial model antigen, in immunologically mature 3-week-old chickens. In contrast, no improvement of antibody either type of chicken IFN was co-injected with inactivated Infectious Bursal Disease Virus (IBDV) antigen. TT-specific antibody formation was marginally increased by co-injection of recombinant E. coli-expressed chicken IL-1beta. Combined administration of IFN-alpha/beta plus IFN-gamma or IL-beta increased responses to TT in an additive, but not synergistic fashion. Remarkably, no augmentation of antibody responses specific for TT, nor IBDV, was noted in day-old birds, receiving IFN-alpha/beta or IFN-gamma as adjuvant. Also, intramuscular immunization of 3-week-old birds, using plasmids encoding IFN-alpha/beta together with TT protein antigen, significantly increased the speed and magnitude of TT-specific antibody responses. Plasmids encoding chicken IL-beta or IFN-gamma had a minimal or inhibitory effect, respectively. These data indicate a potential for chicken cytokines as immunoadjuvant for particular types of chicken vaccine antigens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10715530     DOI: 10.1016/s0264-410x(99)00537-x

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  A novel method to incorporate bioactive cytokines as adjuvants on the surface of virus particles.

Authors:  Yufang Yang; David Leggat; Andrew Herbert; Paul C Roberts; Roys S Sundick
Journal:  J Interferon Cytokine Res       Date:  2009-01       Impact factor: 2.607

2.  Evaluation of a polysaccharide conjugate vaccine to reduce colonization by Campylobacter jejuni in broiler chickens.

Authors:  Douglas C Hodgins; Neda Barjesteh; Michael St Paul; Zuchao Ma; Mario A Monteiro; Shayan Sharif
Journal:  BMC Res Notes       Date:  2015-06-02

3.  Effects of Chicken Interferon Gamma on Newcastle Disease Virus Vaccine Immunogenicity.

Authors:  Stivalis Cardenas-Garcia; Robert P Dunwoody; Valerie Marcano; Diego G Diel; Robert J Williams; Robert M Gogal; Corrie C Brown; Patti J Miller; Claudio L Afonso
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

Review 4.  Infectious bursal disease virus in poultry: current status and future prospects.

Authors:  Tamiru Negash Alkie; Silke Rautenschlein
Journal:  Vet Med (Auckl)       Date:  2016-01-19

5.  Avian reovirus sigma C enhances the mucosal and systemic immune responses elicited by antigen-conjugated lactic acid bacteria.

Authors:  Kuan-Hsun Lin; Ai-Ping Hsu; Jui-Hung Shien; Tien-Jye Chang; Jiunn-Wang Liao; Jeng-Rung Chen; Chuen-Fu Lin; Wei-Li Hsu
Journal:  Vaccine       Date:  2012-04-21       Impact factor: 3.641

6.  Infectious bursal disease virus in chickens: prevalence, impact, and management strategies.

Authors:  Sohini Dey; Dinesh C Pathak; Narayan Ramamurthy; Hemanta Kumar Maity; Madhan Mohan Chellappa
Journal:  Vet Med (Auckl)       Date:  2019-08-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.